ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
Personal Information
Organization / Workplace
Tampa/St. Petersburg, Florida Area United States
Occupation
SVP, Integrated Access & Outcomes Solutions
Industry
Medical / Health Care / Pharmaceuticals
Website
About
In this increasingly cost-conscious drug development and commercialisation environment, value is at the forefront of the minds of patients, payers, HCP's, and policymakers. ICON's Access, Commercialisation & Communications (ACC) integrated team of industry experts provide life-science clients with strategic guidance and workable tactical solutions to support commercial success around the globe. ACC’s seamless integration of pricing, HEOR, publication/value communication, reimbursement, market access, HTA, patient insights and creative services efficiently delivers cross-functional customized solutions that drive the commercial success of our clients’ products.
Contact Details

Presentations(12)Ìý

See all
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic InformationWhat’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information
Ìý
F5 Outcomes based contracting 040416 ARSmm
F5 Outcomes based contracting 040416 ARSmmF5 Outcomes based contracting 040416 ARSmm
F5 Outcomes based contracting 040416 ARSmm
Ìý
EBI inVentiv Market Access Virtual Conference
EBI inVentiv Market Access Virtual ConferenceEBI inVentiv Market Access Virtual Conference
EBI inVentiv Market Access Virtual Conference
Ìý

Documents(2)Ìý

The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Technologies
The Rise of Value-Based Contracting for Biopharmaceuticals and Medical TechnologiesThe Rise of Value-Based Contracting for Biopharmaceuticals and Medical Technologies
The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Technologies
Ìý
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic InformationWHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information
WHITE PAPER: What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance on Communication of Healthcare Economic Information
Ìý